• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶基因多态性与经皮腔内冠状动脉成形术后冠状动脉再狭窄的风险:来自 33 项队列研究的证据。

Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies.

机构信息

Department of Cardiology, The first people's hospital of Wenling, Wenling, Zhejiang, People's Republic of China.

出版信息

PLoS One. 2013 Sep 30;8(9):e75285. doi: 10.1371/journal.pone.0075285. eCollection 2013.

DOI:10.1371/journal.pone.0075285
PMID:24098690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3787085/
Abstract

BACKGROUND

In the past decade, a number of cohort studies studies have been carried out to investigate the relationship between the insertion/deletion polymorphism of the gene encoding angiotensin-converting enzyme and risk of restenosis after percutaneous transluminal coronary angioplasties in patients. However, these studies have yielded contradictory results. Genetic association studies addressing this issue are frequently hampered by insufficient power. We therefore performed a meta-analysis of the published studies to clarify this inconsistency and to establish a comprehensive picture of the relationship between ACE I/D polymorphism and post-PTCA restenosis risk.

METHODS

Databases including Pubmed, EMBASE, ISI Web of Science, EBSCO, Cochrane Library databases and CNKI were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. The random-effects model was applied, addressing heterogeneity and publication bias.

RESULTS

A total of 33 cohort studies involving 11,099 subjects were included. In a combined analysis, the OR for post-PTCA restenosis of the ACE DD genotype was 1.61 (95% CI: 1.27-2.04; P<10(-5)). In the subgroup analysis by intervention, significantly increased risks were also found in PTCA-stent and PTCA-balloon for the DD genotype of the polymorphism.

CONCLUSIONS

Our meta-analysis showed that the DD genotype of ACE I/D polymorphism was significantly associated with increased risk of restenosis, particularly for PTCA-stent.

摘要

背景

在过去的十年中,已经进行了许多队列研究,以研究血管紧张素转换酶基因编码的插入/缺失多态性与经皮腔内冠状动脉成形术后再狭窄风险之间的关系。然而,这些研究产生了相互矛盾的结果。解决这个问题的遗传关联研究经常受到效力不足的阻碍。因此,我们对已发表的研究进行了荟萃分析,以阐明这种不一致,并全面了解 ACE I/D 多态性与经皮腔内冠状动脉成形术后再狭窄风险之间的关系。

方法

检索 Pubmed、EMBASE、ISI Web of Science、EBSCO、Cochrane 图书馆数据库和中国知网(CNKI)等数据库,以查找相关研究。使用优势比(OR)及其 95%置信区间(CI)来评估关联的强度。应用随机效应模型来解决异质性和发表偏倚。

结果

共纳入 33 项队列研究,涉及 11099 名患者。综合分析显示,ACE DD 基因型与经皮腔内冠状动脉成形术后再狭窄的 OR 为 1.61(95%CI:1.27-2.04;P<10(-5))。按干预方式进行亚组分析,发现该多态性的 DD 基因型在经皮腔内冠状动脉成形术支架和球囊中也显著增加了风险。

结论

我们的荟萃分析表明,ACE I/D 多态性的 DD 基因型与再狭窄风险显著相关,尤其是对于经皮腔内冠状动脉成形术支架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ea/3787085/df899354ed54/pone.0075285.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ea/3787085/2c56dc72a7bc/pone.0075285.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ea/3787085/0964367eb24b/pone.0075285.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ea/3787085/df899354ed54/pone.0075285.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ea/3787085/2c56dc72a7bc/pone.0075285.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ea/3787085/0964367eb24b/pone.0075285.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ea/3787085/df899354ed54/pone.0075285.g003.jpg

相似文献

1
Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies.血管紧张素转换酶基因多态性与经皮腔内冠状动脉成形术后冠状动脉再狭窄的风险:来自 33 项队列研究的证据。
PLoS One. 2013 Sep 30;8(9):e75285. doi: 10.1371/journal.pone.0075285. eCollection 2013.
2
Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects.血管紧张素转换酶插入或缺失基因变异与冠状动脉再狭窄风险的关系:基于11193名受试者的证据
PLoS One. 2013 Dec 13;8(12):e83415. doi: 10.1371/journal.pone.0083415. eCollection 2013.
3
A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias.血管紧张素转换酶基因多态性与经皮腔内冠状动脉血管重建术后再狭窄的荟萃分析:发表偏倚的证据
Am Heart J. 2002 Nov;144(5):760-8. doi: 10.1067/mhj.2002.125509.
4
The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.血管紧张素转换酶基因多态性、冠状动脉疾病与支架再狭窄之间的关系:血管紧张素转换酶抑制剂在糖尿病患者支架再狭窄中的作用。
Int Heart J. 2005 Sep;46(5):889-97. doi: 10.1536/ihj.46.889.
5
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.血管紧张素转换酶基因插入/缺失多态性与冠状动脉成形术后再狭窄风险
Lancet. 1995 Apr 22;345(8956):1013-6. doi: 10.1016/s0140-6736(95)90756-4.
6
Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.冠状动脉支架内再狭窄的预测因素:血管紧张素转换酶基因多态性及血管紧张素转换酶抑制剂治疗的重要性。
J Am Coll Cardiol. 2001 Nov 1;38(5):1434-9. doi: 10.1016/s0735-1097(01)01580-7.
7
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies.血管紧张素转换酶插入/缺失多态性与冠状动脉再狭窄:16项研究的荟萃分析
BMJ. 2002 Sep 7;325(7363):517-20. doi: 10.1136/bmj.325.7363.517.
8
Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis.血管紧张素转换酶基因插入/缺失多态性与经皮冠状动脉介入治疗后冠状动脉再狭窄风险的相关性:一项荟萃分析。
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):844-50. doi: 10.1177/1470320315588233. Epub 2015 Jul 20.
9
Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.血管紧张素转换酶插入/缺失多态性不影响冠状动脉支架植入术后的再狭窄率。
Cardiology. 2002;97(1):29-36. doi: 10.1159/000047416.
10
Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.血管紧张素转换酶抑制剂对经皮腔内冠状动脉成形术后再狭窄影响的药物遗传学分析。
Angiology. 1999 Oct;50(10):811-22. doi: 10.1177/000331979905001005.

引用本文的文献

1
Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma.血管内皮相关基因遗传多态性对转移性肾细胞癌患者阿昔替尼临床结局的影响。
Cancer Biol Ther. 2024 Dec 31;25(1):2312602. doi: 10.1080/15384047.2024.2312602. Epub 2024 Feb 7.

本文引用的文献

1
The role of RAS in the pathogenesis of preeclampsia.肾素-血管紧张素系统(RAS)在子痫前期发病机制中的作用。
Curr Hypertens Rep. 2006 May;8(2):144-52. doi: 10.1007/s11906-006-0011-1.
2
Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.经皮冠状动脉介入治疗后的再狭窄与血管紧张素 II 1 型受体 1166A/C 多态性相关,但与血管紧张素转换酶、血管紧张素 II 受体、血管紧张素原或血红素加氧酶-1 的多态性无关。
Pharmacogenet Genomics. 2006 May;16(5):331-7. doi: 10.1097/01.fpc.0000205001.07054.fa.
3
Effects of angiotensin-converting enzyme inhibitors or an angiotensin receptor blocker in combination with aspirin and cilostazol on in-stent restenosis.
血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂联合阿司匹林和西洛他唑对支架内再狭窄的影响。
Int Heart J. 2006 Mar;47(2):173-84. doi: 10.1536/ihj.47.173.
4
The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.血管紧张素转换酶基因多态性、冠状动脉疾病与支架再狭窄之间的关系:血管紧张素转换酶抑制剂在糖尿病患者支架再狭窄中的作用。
Int Heart J. 2005 Sep;46(5):889-97. doi: 10.1536/ihj.46.889.
5
Two quantitative trait loci affect ACE activities in Mexican-Americans.两个数量性状基因座影响墨西哥裔美国人的血管紧张素转换酶活性。
Hypertension. 2004 Feb;43(2):466-70. doi: 10.1161/01.HYP.0000111830.36999.94. Epub 2004 Jan 5.
6
Statistical aspects of the analysis of data from retrospective studies of disease.疾病回顾性研究数据的统计分析方面
J Natl Cancer Inst. 1959 Apr;22(4):719-48.
7
Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis.血管紧张素转换酶基因多态性与颈动脉壁厚度:一项荟萃分析。
Stroke. 2003 Jul;34(7):1634-9. doi: 10.1161/01.STR.0000077926.49330.64. Epub 2003 Jun 12.
8
Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.血管紧张素转换酶抑制对冠状动脉支架置入术后再狭窄的影响。
Am J Cardiol. 2003 Jan 15;91(2):154-8. doi: 10.1016/s0002-9149(02)03101-6.
9
The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis.内皮型一氧化氮合酶(Glu298Asp和-786T>C)基因多态性与冠状动脉支架内再狭窄相关。
Eur Heart J. 2002 Dec;23(24):1955-62. doi: 10.1053/euhj.2002.3400.
10
Inflammation and restenosis in the stent era.支架时代的炎症与再狭窄
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1769-76. doi: 10.1161/01.atv.0000037100.44766.5b.